Die Life-SMS-Methodik

Zusammenfassung

Die MS wird von zahlreichen genetischen und Umweltfaktoren beeinflusst. Klassische, schulmedizinische Behandlungsansätze versprechen bisher allenfalls eine Abschwächung des Verlaufs. Das Projekt Life-SMS (Lebensstil-Strategien bei MS) betrachtet das Thema MS unter einem systemischen Ansatz. Auf Basis verfügbarer wissenschaftlicher Studien zum Themenkomplex Lebensstil, Umwelteinflüsse und Stabilisierung des Systems Mensch − speziell des Immunsystems − wird eine Methodik entwickelt, die unabhängig von und kompatibel mit jeglichen medikamentösen Therapien ist. Die Life-SMS-Methodik eröffnet Betroffenen die Möglichkeit, eigenverantwortlich mit der Krankheit umzugehen und das Paradigma des progressiven Verlaufs zu überwinden.

Abstract

MS is influenced by numerous genetic and environmental factors. Up to now, only a mitigation of the course of the disease can be achieved with classical treatment approaches of orthodox medicine. The project Life-SMS (lifestyle strategies in the case of MS) deals with the topic MS using a systemic approach. Based on existing scientific studies on the topics of lifestyle, environmental influences, and stabilization of the human system − especially of the immune system − a methodology is developed, which is independent of and compatible with any drug therapy. The methodology of Life-SMS allows the people affected, to deal with the disease on their own responsibility and to overcome the paradigm of the progressive course.

Schlüsselwörter

Life-SMS-Methodik - MS - Lebensstilmaßnahmen - Selbsthilfe

Keywords

Methodology of Life-SMS - MS - lifestyle measures - self-help

• Literatur

• 1 Corthals AP. Multiple sclerosis is not a disease of the immune system. The Quarterly Review of Biology 2011; 86: 287-321 DOI: 10.1086/662453.
• 2 http://www.overcomingmultiplesclerosis.org/ George Jelinek NHMRC Clinical Centre for Research Excellence in Diabetes, Department of Medicine, University of Melbourne (St Vincent’s Health).
• 3 Jelinek G. Overcoming multiple sclerosis. An evidence-based guide to recovery. Sidney: Allen & Unwin; 2010
• 4 Hadgkiss E, Jelinek GA, Weiland TJ et al. Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis. Neurol Sci 2012; DOI: 10.1007/s10072-012-0982-4.
• 5 Marrie RA, Rudick R, Horwitz R. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 2010; 74: 1041-1047 DOI: 10.1212/WNL.0b013e3181d6b125.
• 6 Oliveira SR, Simão ANC, Kallaur AP et al. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress. Nutrition 2014; 30: 268-273 DOI: 10.1016/j.nut.2013.08.001.
• 7 Ringe JD, Kipshoven C. Vitamin D-insufficiency: An estimate of the situation in Germany. dermatoendocrinology 2012; 4: 72-80 DOI: 10.4161/derm.19829.
• 8 Correale J, Farez MF. Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid. Journal of Neuroimmunology 2013; 261: 134-140
• 9 Pierrot-Deseilligny C, Souberbielle JC. Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. Therapeutic Advances in Neurological Disorders 2013; 6: 81-116 DOI: 10.1177/1756285612473513.
• 10 Stewart N, Simpson S, van der Mei I et al. Interferon- and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS. Neurology 2012; 79: 254-260 DOI: 10.1212/WNL.0b013e31825fded9.
• 11 Scott TF, Hackett CT, Dworek DC et al. Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients. J Neurol Sci 2013; 330: 27-31 DOI: 10.1016/j.jns.2013.03.020.
• 12 Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 2008; 233: 674-688
• 13 van Meeteren ME, Teunissen CE, Dijkstra CD et al. Antioxidants and polyunsaturated fatty acids in multiple sclerosis. Eur J Clin Nutr 2005; 59: 1347-1361 DOI: 10.1038/sj.ejcn.1602255.
• 14 Aggarwal BB, Prasad S, Reuter S. Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: „reverse pharmacology“ and „bedside to bench“ approach. Curr Drug Targets 2011; 12: 1595-1653
• 15 Döring A, Pfueller CF, Paul F. Exercise in multiple sclerosis − an integral component of disease management. EPMA Journal 2012; 3: 2- DOI: 10.1007/s13167-011-0136-4.
• 16 Beier M, Bombardier CH, Hartoonian N. Improved physical fitness correlates with improved cognition in multiple sclerosis. Arch Phys Med Rehabil 2014; DOI: 10.1016/j.apmr.2014.02.017.
• 17 Ackerman KD. Stressful life events precede exacerbations of multiple sclerosis. Psychosomatic Medicine 2002; 64: 916-920 DOI: 10.1097/01.PSY.0000038941.33335.40.
• 18 Burns MN, Nawacki E, Kwasny MJ et al. Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?. Psychol Med 2014; 44: 349-359 DOI: 1017/S0033291713000755.
• 19 Oken BS, Kishiyama S, Zajdel D. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 2004; 62: 2058-2064